Analyst Price Targets — SHC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 24, 2026 8:51 am | — | UBS | $19.00 | $15.84 | TheFly | Sotera Health price target raised to $19 from $18 at Barclays |
| June 5, 2026 6:37 am | Evie Koslosky | Goldman Sachs | $20.00 | $15.57 | StreetInsider | Goldman Sachs Starts Sotera Health (SHC) at Buy |
| April 14, 2026 10:43 am | — | Barclays | $18.00 | $15.70 | TheFly | Sotera Health price target lowered to $18 from $20 at Barclays |
| January 9, 2026 10:15 am | Jason Bednar | Piper Sandler | $24.00 | $18.81 | TheFly | Sotera Health upgraded to Overweight from Neutral at Piper Sandler |
| January 8, 2026 9:05 pm | Ryan Halstead | RBC Capital | $24.00 | $18.81 | StreetInsider | RBC Capital Starts Sotera Health (SHC) at Outperform |
| November 5, 2025 2:22 pm | — | Piper Sandler | $17.00 | $16.15 | TheFly | Sotera Health price target raised to $17 from $15 at Piper Sandler |
| November 5, 2025 11:20 am | — | Barclays | $20.00 | $16.43 | TheFly | Sotera Health price target raised to $20 from $19 at Barclays |
| October 2, 2025 10:44 am | — | Barclays | $19.00 | $16.19 | TheFly | Sotera Health price target raised to $19 from $17 at Barclays |
| May 5, 2025 8:22 am | Matthew Sykes | Goldman Sachs | $17.00 | $12.92 | TheFly | Sotera Health upgraded to Buy from Neutral at Goldman Sachs |
| December 5, 2024 9:03 pm | David Windley | Jefferies | $15.00 | $12.98 | StreetInsider | Sotera Health (SHC) PT Lowered to $15 at Jefferies |
Latest News for SHC
Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 31,838,253 shares of its common stock, par value $0.01 per share. All 31,838,253 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders.
Sotera Health offers sterilization and lab testing for healthcare and life sciences clients, supporting global regulatory compliance.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SHC.
U.S. House Trading
No House trades found for SHC.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.